A detailed history of Virtu Financial LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Virtu Financial LLC holds 19,980 shares of NVO stock, worth $2.03 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
19,980
Holding current value
$2.03 Million
% of portfolio
0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $2.45 Million - $2.94 Million
19,980 New
19,980 $2.85 Million
Q4 2023

Feb 26, 2024

SELL
$87.78 - $105.45 $1.61 Million - $1.94 Million
-18,356 Reduced 88.39%
2,410 $249,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.89 Million - $4.14 Million
20,766 New
20,766 $1.89 Million
Q1 2022

May 17, 2022

SELL
$93.1 - $112.54 $369,420 - $446,558
-3,968 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$95.88 - $117.08 $380,451 - $464,573
3,968 New
3,968 $444,000
Q1 2021

May 19, 2021

SELL
$67.06 - $75.82 $727,869 - $822,950
-10,854 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$63.89 - $73.8 $693,462 - $801,025
10,854 New
10,854 $758,000
Q2 2020

Aug 07, 2020

SELL
$58.54 - $67.94 $270,162 - $313,543
-4,615 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$49.86 - $58.26 $18,996 - $22,197
381 Added 9.0%
4,615 $267,000
Q3 2019

Nov 20, 2019

SELL
$47.54 - $53.43 $19,919 - $22,387
-419 Reduced 9.0%
4,234 $219,000
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $217,713 - $244,142
4,653 New
4,653 $237,000
Q4 2018

Jan 16, 2019

SELL
$41.54 - $47.25 $304,446 - $346,295
-7,329 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $342,704 - $375,537
7,329 New
7,329 $345,000
Q2 2018

Jul 30, 2018

SELL
$44.29 - $50.42 $750,184 - $854,013
-16,938 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$44.29 - $50.42 $750,184 - $854,013
16,938 New
16,938 $781,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.